Company / Free Cash Flow
Apyx Medical Corp Free Cash Flow History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Free Cash Flow
-$9.1M
FY2025
5-year range
-$21.3M / -$9.1M
FY2021-FY2025
Trend
+51.4%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Free Cash Flow has fluctuated over the past 10 years, ranging from -$21M in FY2023 to -$1M in FY2016.
Based on SEC 10-K filings.
-$9M in FY2025.
Improved from -$21M to -$9M over the past 2 years.
Free Cash Flow over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, free cash flow increased 51.4% year-over-year.
- Peak free cash flow was recorded in FY2016.
- Lowest free cash flow in the period was in FY2023.
Company context
Key Data Points
- Altman Z-Score -0.02 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Free Cash FlowValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$9.1M | +51.4% |
| FY2024 | -$18.8M | +11.8% |
| FY2023 | -$21.3M | +0.0% |
| FY2022 | -$21.3M | -27.9% |
| FY2021 | -$16.6M | +15.8% |
| FY2020 | -$19.8M | -356.9% |
| FY2019 | -$4.3M | -38.6% |
| FY2018 | -$3.1M | +49.7% |
| FY2017 | -$6.2M | -492.8% |
| FY2016 | -$1.0M | +66.5% |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026